Expect FY10 topline to grow by 20-25%: Glenmark

Back


In an interview with CNBC-TV18, Glenn Saldanha, Managing Director and Chief Executive Officer, Glenmark Pharmaceuticals spoke about the companys results.

Category: News
Uploaded: October 29th, 2009 @ 11:30 am
Author: moneycontrol

Length: 05:44
Rating:
Views:

Tags: glenmark pharma glenmark pharmaceuticals glenn saldanha glenmark result glenmark q2fy10 result net profit melogliptin oglemilast trileptal oxcarb glenmark generics

Related Video Links:


» View Video Comments For Expect FY10 topline to grow by 20-25%: Glenmark
» View moneycontrol's Other Uploaded Videos

Video Thumbnails:


Thumbnail #1 Video Thumbnail #1:
Thumbnail #2 Video Thumbnail #2:
Thumbnail #3 Video Thumbnail #3:


Video Embedding Code:


Video Url:


Embed Code:

* Embed this video on your website, social bookmark, myspace, or blog.